Genenta Science: Court Upholds Corporate Purpose Amendment

The Court of Milan ruled in favor of Genenta Science, determining that the company's interest in maintaining the effectiveness of an amendment to its corporate purpose outweighed the alleged prejudice asserted by plaintiffs. As a result, the amendment is now fully effective, and a previously issued suspension order has been removed from the Italian Companies Register. The underlying civil action challenging the validity of shareholder resolutions from May 2, 2024, and October 29, 2025, remains pending, and Genenta Science plans to vigorously defend these resolutions.